newsfilter
← Latest News
Business Wire·

CytRx Announces Distribution of Series D Preferred Stock to Holders of Its Common Stock

CytRx Corporation (OTCQB:CYTR) ("CytRx" or the "Company"), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today announced that its Board of Directors declared a dividend of one one-thousandth of a s